Deep Track Capital, LP Apellis Pharmaceuticals, Inc. Transaction History
Deep Track Capital, LP
- $2.71 Billion
- Q3 2024
A detailed history of Deep Track Capital, LP transactions in Apellis Pharmaceuticals, Inc. stock. As of the latest transaction made, Deep Track Capital, LP holds 4,400,654 shares of APLS stock, worth $150 Million. This represents 4.68% of its overall portfolio holdings.
Number of Shares
4,400,654
Previous 2,500,000
76.03%
Holding current value
$150 Million
Previous $95.9 Million
32.34%
% of portfolio
4.68%
Previous 3.15%
Shares
3 transactions
Others Institutions Holding APLS
# of Institutions
309Shares Held
115MCall Options Held
3.85MPut Options Held
1.09M-
Wellington Management Group LLP Boston, MA15.6MShares$530 Million0.08% of portfolio
-
Eco R1 Capital, LLC San Francisco, CA11.9MShares$405 Million14.88% of portfolio
-
Avoro Capital Advisors LLC New York, NY11.1MShares$378 Million4.82% of portfolio
-
Vanguard Group Inc Valley Forge, PA9.82MShares$334 Million0.01% of portfolio
-
Black Rock Inc. New York, NY5.8MShares$197 Million0.01% of portfolio
About Apellis Pharmaceuticals, Inc.
- Ticker APLS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 109,865,000
- Market Cap $3.74B
- Description
- Apellis Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of therapeutic compounds through the inhibition of the complement system for autoimmune and inflammatory diseases. The company's lead product candidate is pegcetacoplan that is in Phase III clinical trials for...